Resveratrol analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 1, 2008, Pages 27-35

  Ma, Zengshuan ^a   Molavi, Ommoleila ^a   Haddadi, Azita ^a   Lai, Raymond ^a   Gossage, Robert A ^b   Lavasanifar, Afsaneh ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ACADIA UNIVERSITY   (Canada)

Author keywords

Apoptosis; Cell cycle; DMU 212; Resveratrol; Stat3; Tubulin

Indexed keywords

3,4,5,4' TETRAMETHOXYSTILBENE; APOPTOSIS REPRESSOR WITH CASPASE RECRUITMENT DOMAIN; CYCLIN D1; DMU 212; RESVERATROL; STAT3 PROTEIN; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL GROWTH; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; MITOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BIOPOLYMERS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; ESTROGENS; FEMALE; HUMANS; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; STAT3 TRANSCRIPTION FACTOR; STILBENES; TUBULIN;

EID: 53149112743     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0704-z     Document Type: Article

References (38)

1. P Signorelli R Ghidoni 2005 Resveratrol as an anticancer nutrient: molecular basis, open questions and promises J Nutr Biochem 16 449 466
2. BB Aggarwal S Shishodia 2006 Molecular targets of dietary agents for prevention and therapy of cancer Biochem Pharmacol 71 1397 1421
3. CA de la Lastra I Villegas 2005 Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications Mol Nutr Food Res 49 405 430
4. AR Jazirehi B Bonavida 2004 Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis Mol Cancer Ther 3 71 84
5. A Kotha M Sekharam L Cilenti K Siddiquee A Khaled AS Zervos B Carter J Turkson R Jove 2006 Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein Mol Cancer Ther 5 621 629
6. A Bhardwaj G Sethi S Vadhan-Raj C Bueso-Ramos Y Takada U Gaur AS Nair S Shishodia BB Aggarwal 2007 Resveratrol inhibits proliferation, induces apoptosis and overcomes chemoresistance through downregulation of STAT3 and nuclear factor-{kappa}B-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells Blood 109 2293 2302
7. S Garvin K Ollinger C Dabrosin 2006 Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo Cancer Lett 231 113 122
8. TC Hsieh Z Wang CV Hamby JM Wu 2005 Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53 Biochem Biophys Res Commun 334 223 230
9. NF Trincheri G Nicotra C Follo R Castino C Isidoro 2007 Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D Carcinogenesis 28 922 931
10. G Notas AP Nifli M Kampa J Vercauteren E Kouroumalis E Castanas 2006 Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation Biochim Biophys Acta 1760 1657 1666
11. J Lu CH Ho G Ghai KY Chen 2001 Resveratrol analog, 3,4,5,4′- tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts Carcinogenesis 22 321 328
12. S Sale RD Verschoyle D Boocock DJ Jones N Wilsher KC Ruparelia GA Potter PB Farmer WP Steward AJ Gescher 2004 Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene Br J Cancer 90 736 744
13. S Sale RG Tunstall KC Ruparelia GA Potter WP Steward AJ Gescher 2005 Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells Int J Cancer 115 194 201
14. A Gosslau M Chen CT Ho KY Chen 2005 A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts Br J Cancer 92 513 521
15. PJ Real A Sierra A De Juan JC Segovia JM Lopez-Vega JL Fernandez-Luna 2002 Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells Oncogene 21 7611 7618
16. J Turkson R Jove 2000 STAT proteins: novel molecular targets for cancer drug discovery Oncogene 19 6613 6626
17. GG Cross CR Eisnor RA Gossage HA Jenkins 2006 Oxazoline chemistry Part 12. A metal-mediated synthesis of DMU-212: X-ray diffraction studies of an important anti-cancer agent Tetrahedron Lett 47 2245 2247
18. P Giannakakou DL Sackett YK Kang Z Zhan JT Buters T Fojo MS Poruchynsky 1997 Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization J Biol Chem 272 17118 17125
19. S Yang Q Zhou X Yang 2007 Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells Biochim Biophys Acta 1773 903 911
20. BS Wung MC Hsu CC Wu CW Hsieh 2005 Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation Life Sci 78 389 397
21. J Sun MA Blaskovich R Jove SK Livingston D Coppola SM Sebti 2005 Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity Oncogene 24 3236 3245
22. GR Pettit MP Grealish MK Jung E Hamel RK Pettit JC Chapuis JM Schmidt 2002 Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate J Med Chem 45 2534 2542
23. Y Schneider P Chabert J Stutzmann D Coelho A Fougerousse F Gosse JF Launay R Brouillard F Raul 2003 Resveratrol analog (Z)-3,5,4′- trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization Int J Cancer 107 189 196
24. T Lindahl MS Satoh GG Poirier A Klungland 1995 Post-translational modification of poly (ADP-ribose) polymerase induced by DNA strand breaks Trends Biochem Sci 20 405 411
25. O Coqueret 2002 Linking cyclins to transcriptional control Gene 299 35 55
26. Q Lin R Lai LR Chirieac C Li VA Thomazy I Grammatikakis GZ Rassidakis W Zhang Y Fujio K Kunisada SR Hamilton HM Amin 2005 Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells Am J Pathol 167 969 980
27. V Mamidipudi J Zhang KC Lee CA Cartwright 2004 RACK1 regulates G1/S progression by suppressing Src kinase activity Mol Cell Biol 24 6788 6798
28. LG Wang XM Liu W Kreis DR Budman 1999 The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review Cancer Chemother Pharmacol 44 355 361
29. KN Bhalla 2003 Microtubule-targeted anticancer agents and apoptosis Oncogene 22 9075 9086
30. CI Rubin GF Atweh 2004 The role of stathmin in the regulation of the cell cycle Cell Biochem 93 242 250
31. EK Rowinsky 1997 The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents Annu Rev Med 48 353 374
32. JA Hadfield S Ducki N Hirst AT McGown 2003 Tubulin and microtubules as targets for anticancer drugs Prog Cell Cycle Res 5 309 325
33. KM Bhat V Setaluri 2007 Microtubule-associated proteins as targets in cancer chemotherapy Clin Cancer Res 13 2849 2854
34. S Kim SY Min SK Lee WJ Cho 2003 Comparative molecular field analysis study of stilbene derivatives active against A549 lung carcinoma Chem Pharm Bull (Tokyo) 51 516 521
35. H Park SE Aiyar P Fan J Wang W Yue T Okouneva C Cox MA Jordan L Demers H Cho S Kim RX Song RJ Santen 2007 Effects of tetramethoxystilbene on hormone-resistant breast cancer cells: biological and biochemical mechanisms of action Cancer Res 67 5717 5726
36. V Ganansia-Leymarie P Bischoff JP Bergerat V Holl 2003 Signal transduction pathways of taxanes-induced apoptosis Curr Med Chem Anticancer Agents 3 291 306
37. L Drew RL Fine TN Do GP Douglas DP Petrylak 2002 The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells Clin Cancer Res 8 3922 3932
38. DC Ng BH Lin CP Lim G Huang T Zhang V Poli X Cao 2006 Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin J Cell Biol 172 245 257